Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA.
Alexander N GorelickMinsoo KimWalid K ChatilaKonnor LaAbraham Ari HakimiMichael F BergerBarry S TaylorPayam A GammageEd ReznikPublished in: Nature metabolism (2021)
Mitochondrial DNA (mtDNA) encodes protein subunits and translational machinery required for oxidative phosphorylation (OXPHOS). Using repurposed whole-exome sequencing data, in the present study we demonstrate that pathogenic mtDNA mutations arise in tumours at a rate comparable to those in the most common cancer driver genes. We identify OXPHOS complexes as critical determinants shaping somatic mtDNA mutation patterns across tumour lineages. Loss-of-function mutations accumulate at an elevated rate specifically in complex I and often arise at specific homopolymeric hotspots. In contrast, complex V is depleted of all non-synonymous mutations, suggesting that impairment of ATP synthesis and mitochondrial membrane potential dissipation are under negative selection. Common truncating mutations and rarer missense alleles are both associated with a pan-lineage transcriptional programme, even in cancer types where mtDNA mutations are comparatively rare. Pathogenic mutations of mtDNA are associated with substantial increases in overall survival of colorectal cancer patients, demonstrating a clear functional relationship between genotype and phenotype. The mitochondrial genome is therefore frequently and functionally disrupted across many cancers, with major implications for patient stratification, prognosis and therapeutic development.
Keyphrases
- mitochondrial dna
- copy number
- genome wide
- papillary thyroid
- magnetic resonance
- squamous cell
- risk assessment
- intellectual disability
- single cell
- magnetic resonance imaging
- small molecule
- study protocol
- squamous cell carcinoma
- big data
- data analysis
- climate change
- genome wide identification
- artificial intelligence
- functional connectivity